10-Q

Company

Mereo BioPharma Group plc

Filed

August 12, 2025

Period of Report

June 30, 2025

Accession Number

0001193125-25-178489

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →